0000899243-22-034264.txt : 20221026 0000899243-22-034264.hdr.sgml : 20221026 20221026161545 ACCESSION NUMBER: 0000899243-22-034264 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221020 FILED AS OF DATE: 20221026 DATE AS OF CHANGE: 20221026 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Atillasoy Ercem CENTRAL INDEX KEY: 0001818802 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39409 FILM NUMBER: 221333422 MAIL ADDRESS: STREET 1: C/O ALLOVIR, INC. STREET 2: 139 MAIN STREET, SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allovir, Inc. CENTRAL INDEX KEY: 0001754068 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 831971007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (617) 433-2605 MAIL ADDRESS: STREET 1: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: ViraCyte, Inc. DATE OF NAME CHANGE: 20180924 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2022-10-20 2022-10-24 0 0001754068 Allovir, Inc. ALVR 0001818802 Atillasoy Ercem C/O ALLOVIR, INC. 1100 WINTER STREET WALTHAM MA 02451 0 1 0 0 See Remarks Common Stock 2022-10-20 4 S 0 568 9.3607 D 132899 D Common Stock 2022-10-21 4 S 0 1527 8.4843 D 131372 D Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.40 to $8.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. This Form 4/A is being filed correct the transaction dates reported in the original Form 4 filed on October 24, 2022. Officer Title: Chief Regulatory and Safety Officer /s/ Brett Hagen, as Attorney-in-Fact 2022-10-26